Signaling through c-Kit remains pivotal to all 3 GIST cell lines, however, inhibition of c-Met and HER1 provides an additional mechanism to turn off dominant c-Kit signaling. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.